EL Estée Lauder Companies (The)
The turnaround is real and margins are rebuilding, but $105 already prices in a return to peak-era profitability.
The story
Estée Lauder owns prestige beauty franchises (Estée Lauder, Clinique, La Mer, MAC, Tom Ford) whose brand equity remains intact, but it is a mature company midway through a turnaround after the China/travel-retail collapse. Revenue has turned up (+5% TTM) and reported margins have recovered from -4.8% to 5.7%, though restructuring charges still weigh on them. The Beauty Reimagined/PRGP cost program is credible, but getting back to the 18-20% peak margins of 2019-2021 would require the travel-retail boom that inflated those peaks to return.
What changed: revenue returned to growth (+5% TTM vs -8% the prior year) and margins swung positive. So y1 growth moves up 25% (0.04 to 0.05), and failure probability falls from 0.03 to 0.02 because the balance sheet and cash flow look less stressed. Target margin rises modestly to 15.5% as cost savings show up, which is still below peak because travel-retail economics are not coming back. Beta eases to 1.05 as earnings volatility subsides. Even with these more generous drivers, the market price implies margins near 18-20% that I cannot justify.
Value drivers
| Revenue growth (Y1) | 5.0% |
| Terminal growth | 2.5% |
| Forecast horizon | 8y |
| Target operating margin | 15.5% |
| Years to target margin | 6 |
| Sales-to-capital | 1.50 |
| Beta | 1.05 |
| Failure probability | 2.0% |
| Cost of capital (WACC) | 9.0% |
| Terminal WACC | 8.8% |
Valuation bridge
| PV of explicit FCFF | 5.33B |
| PV of terminal value | 11.87B |
| Equity value | 12.30B |
| ÷ shares → per share | $33.95 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 15.80B | 5.0% | 7.3% | 749.34M | 501.63M | 247.71M | 227.25M |
| 2 | 16.54B | 4.6% | 8.9% | 960.49M | 489.09M | 471.39M | 396.74M |
| 3 | 17.24B | 4.3% | 10.6% | 1.19B | 472.43M | 713.13M | 550.62M |
| 4 | 17.92B | 3.9% | 12.2% | 1.42B | 451.62M | 971.66M | 688.27M |
| 5 | 18.56B | 3.6% | 13.9% | 1.67B | 426.69M | 1.25B | 809.30M |
| 6 | 19.16B | 3.2% | 15.5% | 1.93B | 397.74M | 1.53B | 913.57M |
| 7 | 19.71B | 2.9% | 15.5% | 1.99B | 364.91M | 1.62B | 886.23M |
| 8 | 20.20B | 2.5% | 15.5% | 2.03B | 328.42M | 1.71B | 856.25M |
Key risks
- China and Asia travel-retail demand stays depressed or shifts further to local/C-beauty brands
- Restructuring savings get reinvested in advertising and promotion instead of reaching the margin
- Prestige beauty share losses to indie and digital-native brands, plus tariff and FX headwinds
Catalysts
- Quarterly evidence of adjusted operating margin moving toward low double digits on schedule
- Return of positive organic growth in Mainland China and Asian travel retail